merck
Entity, reached from Hormuz.
- Evidence
- 175 documents · 59 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 5 May 2026, last seen 9 Oct 2026
- Measured
- 24% of mentions say something specific about it; the rest only name it
- As of
- 9 Oct 2026
Where this comes from
- AllSci News · 2026-10-08 · Tempus expands role in Moderna and Merck's personalized cancer vaccine commercialization push (opens the source in a new tab)
- 24/7 Wall St. · 2026-10-08 · HP, Merck, and Seagate Just Paid Their Shareholders. Here’s What Landed in Their Accounts. (opens the source in a new tab)
- STAT News · 2026-10-07 · STAT+: Merck suffers a setback in Europe over its new Keytruda formulation (opens the source in a new tab)
- Fierce Pharma · 2026-10-07 · Halozyme stymies subcutaneous Keytruda launch in select European countries as Merck vows to fight patent claims (opens the source in a new tab)
- BioPharma Dive · 2026-10-07 · Halozyme prevails in patent fight with Merck; Enliven readies anticipated leukemia trial (opens the source in a new tab)
- STAT News · 2026-10-06 · STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market (opens the source in a new tab)
- AllSci News · 2026-10-02 · Merck’s tulisokibart delivers first positive Phase II anti-TL1A data in dermatology (opens the source in a new tab)
- Fierce Pharma · 2026-10-02 · Fierce Pharma Asia—AZ’s $2B bet on ivonescimab; Novo buys Hengrui GLP-1; Merck doubles down on KRAS (opens the source in a new tab)
- STAT News · 2026-09-30 · STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more (opens the source in a new tab)
- Fierce Biotech · 2026-09-30 · Merck’s anti-TL1A antibody secures a win in ph. 2 hidradenitis suppurativa trial (opens the source in a new tab)
1 more on file, counted in the evidence above.
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with fda (52 documents)seen together
- co-mentioned with amgen (38 documents)seen together
- co-mentioned with ai (37 documents)seen together
- co-mentioned with china (36 documents)seen together
- co-mentioned with pfizer (34 documents)seen together
- co-mentioned with astrazeneca (33 documents)seen together
- co-mentioned with eli lilly (33 documents)seen together
- co-mentioned with novartis (31 documents)seen together
- co-mentioned with studie (27 documents)seen together
- co-mentioned with roche (25 documents)seen together